PDB25 COSTS AND EFFECTIVENESS OF INSULIN VS. ROSIGLITAZONE IN TYPE 2 DIABETES AFTER METFORMIN MONOTHERAPY FAILURE
May 1, 2008, 00:00
10.1016/S1098-3015(10)70713-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)70713-0/fulltext
Title :
PDB25 COSTS AND EFFECTIVENESS OF INSULIN VS. ROSIGLITAZONE IN TYPE 2 DIABETES AFTER METFORMIN MONOTHERAPY FAILURE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70713-0&doi=10.1016/S1098-3015(10)70713-0
First page :
Section Title :
Open access? :
No
Section Order :
454